DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Reddy's - 2 Erez - 2 Nestle - 1
Top related locs:
India Индия Хайдарабад Россия
Top related orgs:
Reddy's Laboratories - 4 Reddy’s Laboratories - 1 Nestle India - 1 Erez - 1 Минздрав - 1

Search resuls for: "Reddy's Laboratories"


8 mentions found


☆ Dr Reddy's Laboratories' CEO says Nestle has an 'amazing portfolio'
  + stars: | 2024-05-08 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr Reddy's Laboratories' CEO says Nestle has an 'amazing portfolio'Erez Israeli, CEO of Dr Reddy’s Laboratories, discusses its joint venture with Nestle India.
Persons: Reddy's, Nestle, Erez Organizations: Reddy's Laboratories, Reddy’s Laboratories, Nestle India
☆ Dr Reddy's Laboratories' CEO expects 'double digit' growth in most markets in coming quarters
  + stars: | 2024-01-31 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr Reddy's Laboratories' CEO expects 'double digit' growth in most markets in coming quartersErez Israeli, CEO of Dr Reddy's Laboratories, breaks down the company's Q3 earnings.
Persons: Reddy's, Erez Organizations: Reddy's Laboratories
☆ We expect India to eventually be our biggest source of sales, says pharmaceutical company
  + stars: | 2023-07-28 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe expect India to eventually be our biggest source of sales, says pharmaceutical companyErez Israeli of Dr. Reddy's Laboratories says "many companies are not registering the innovation in India."
Organizations: Erez, Reddy's Laboratories Locations: India
☆ India's Glenmark Pharma reports lower Q4 profit as domestic sales weaken
  + stars: | 2023-05-19 | by ( ) www.reuters.com   time to read: +2 min
BENGALURU, May 19 (Reuters) - India's Glenmark Pharmaceuticals Ltd (GLEN.NS) reported a 12.3% decline in fourth-quarter profit on Friday, hurt by higher input costs and lower demand in its domestic drugs business. Consolidated profit before exceptional items and tax fell to 3.09 billion rupees ($37.78 million) for the three months ended March 31, from 3.52 billion rupees a year earlier, the cetirizine maker said in a stock exchange filing. Glenmark, which caters to the therapeutic areas such as diabetes, cardiovascular and oral contraceptives, reported a 11.5% rise in quarterly net sales. Input costs for the quarter rose 11% to 8.77 billion rupees from a year earlier. Glenmark Pharma shares had climbed 9.6% in the March quarter, comfortably outperforming the Nifty Pharma index (.NIPHARM) that fell 4.6%.
☆ In general, price control isn't affecting us, says pharmaceutical company
  + stars: | 2023-05-11 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailIn general, price control isn't affecting us, says pharmaceutical companyErez Israeli of Dr. Reddy's Laboratories says "we are a very diverse business and we're trying to grow in China, in Asia, in America, in India, etc."
☆ Indian shares fall as China COVID surge dampens sentiment
  + stars: | 2022-12-29 | by ( ) www.reuters.com   time to read: +2 min
BENGALURU, Dec 29 (Reuters) - Indian shares fell on Thursday, dragged by broad-based declines, as a surge in COVID cases in China dampened optimism generated by the reopening of the world's second-largest economy. The Nifty 50 index (.NSEI) was down 0.58% at 18,017.85, as of 11:27 a.m. IST, and the S&P BSE Sensex (.BSESN) fell 0.54% to 60,578.03. Forty-five of the Nifty 50 constituents fell, with Tata Consumer (TACN.NS), Tata Motors (TAMO.NS), Grasim (GRAS.NS), Ultratech Cement (ULTC.NS), HDFC (HDFC.NS) and Hindalco Industries (HALC.NS) losing over 1.25%. Several countries, including the United States and India, have made COVID tests mandatory for travellers from China. The stock was the top gainer in Nifty 50 index.
☆ INDIA STOCKS Indian shares seen opening higher to track Asia gains
  + stars: | 2022-10-31 | by ( ) www.reuters.com   time to read: +3 min
BENGALURU, Oct 31 (Reuters) - Indian shares may open higher on Monday, after rising for two consecutive weeks, tracking gains in broader Asia and a fall in oil prices. India's NSE stock futures, listed on the Singapore exchange , were 0.92% higher as of 0242 GMT. The MSCI's broadest index of Asia-Pacific shares outside Japan (.MIAPJ0000PUS) was up 0.8%. Stocks to watch:** Sugar stocks after India, the world's biggest sugar producer, extended restrictions for export by one year through October 2023, the government said in a notification late on Friday. ($1 = 82.2610 Indian rupees)Reporting by Rama Venkat in Bengaluru;Editing by Dhanya Ann ThoppilOur Standards: The Thomson Reuters Trust Principles.
☆ Индия установила новый антирекорд по числу смертей от коронавируса
  + stars: | 2021-05-05 | by ( Mld Media Srl | Степанов Георгий | ) noi.md   time to read: 1 min
В Индии за прошедшие сутки был установлен новый антирекорд смертности от коронавируса: скончались 3780 заразившихся. Общее число умерших от COVID-19 в стране составляет 226 188. Кроме того, в Индии начало расти число новых случаев COVID-19 после трехдневного снижения прироста заболевших. За минувшие сутки в стране было выявлено 382,3 тысячи случаев коронавируса - на 25 тысяч больше, чем накануне. Число заболевших уже вторую неделю подряд превышает 300 тысяч человек в сутки — больше, чем в любой другой стране мира.
Organizations: Reddy's Laboratories, Минздрав Locations: India, Индия, Хайдарабад, Россия
0 next >>
Total: 8